The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple Sclerosis
Open accessAbstract
BACKGROUND AND OBJECTIVES: The optic nerve has been recommended as an additional region for demonstrating dissemination in space (DIS) in diagnostic criteria for multiple sclerosis (MS). The aim of this study was to investigate whether adding the optic nerve region as determined by optical coherence tomography (OCT) as part of the DIS criteria improves the 2017 diagnostic criteria. METHODS: From a prospective observational study, we included patients with a first demyelinating event who had complete information to assess DIS and a spectral domain OCT scan obtained within 180 days. Modified DIS criteria (DIS + OCT) were constructed by adding the optic nerve to the current DIS regions based on validated thresholds for OCT intereye differences. Time to second clinical attack was the primary endpoint. RESULTS: We analyzed 267 patients with MS (mean age 31.3 years [SD 8.1], 69% female) during a median observation period of 59 months (range: 13-98). Adding the optic nerve as a fifth region improved the diagnostic performance by increasing accuracy (DIS + OCT 81.2% vs DIS 65.6%) and sensitivity (DIS + OCT 84.2% vs DIS 77.9%) without lowering specificity (DIS + OCT 52.2% vs DIS 52.2%). Fulfilling DIS + OCT criteria (≥2 of 5 DIS + OCT regions involved) indicated a similar risk of a second clinical attack (hazard ratio [HR] 3.6, CI 1.4-14.5) compared with a 2.5-fold increased risk when fulfilling DIS criteria (HR 2.5, CI 1.2-11.8). When the analysis was conducted according to topography of the first demyelinating event, DIS + OCT criteria performed similarly in both optic neuritis and nonoptic neuritis. DISCUSSION: Addition of the optic nerve, assessed by OCT, as a fifth region in the current DIS criteria improves diagnostic performance by increasing sensitivity without lowering specificity. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that adding the optic nerve as determined by OCT as a fifth DIS criterion to the 2017 McDonald criteria improves diagnostic accuracy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the subgroup of people with at least 5-years of follow-up (n=118), the modified 2017 criteria improved diagnostic accuracy from 65.6% to 81.2%, together with a modest increase in sensitivity, without change in specificity.”
From The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis (2025) · cites this paper as [75]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30470-2 · Cited by 8,167
Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
Freedman, M. S., Thompson, E. J., Deisenhammer, F., Giovannoni, G., Grimsley, G., Keir, G., Öhman, S., Racke, M. K., Sharief, M., Sindic, C. J. M., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.6.865 · Cited by 41
Self-citation
Flagged first, then by citations
Research works printed but not linked: 37
- 10.1002/ana.20703 · DOI · Paper page
- 10.1002/ana.22366 · DOI · Paper page
- 10.1016/s1474-4422(13)70259-x · DOI
- 10.1002/ana.24351 · DOI
- 10.1016/s1474-4422(17)30278-8 · DOI · Paper page
- 10.1093/brain/awz038 · DOI
- 10.1212/wnl.0000000000006207 · DOI
- 10.1016/s1474-4422(10)70168-x · DOI
- 10.1016/j.msard.2020.101988 · DOI
- 10.1212/WNL.0000000000009504 · DOI
- 10.1212/wnl.0000000000009832 · DOI
- 10.1212/wnl.0000000000009840 · DOI
- 10.1111/ene.13443 · DOI
- 10.1097/wno.0000000000000629 · DOI
- 10.1136/jnnp-2021-327468 · DOI
- 10.1016/j.msard.2020.102403 · DOI
- 10.2147/eb.s139417 · DOI
- 10.1016/s1474-4422(15)00393-2 · DOI · Paper page
- 10.1016/s1474-4422(17)30469-6 · DOI · Paper page
- 10.1212/wnl.0000000000011339 · DOI
- 10.1212/wnl.33.11.1444 · DOI · Paper page
- 10.1001/archopht.1985.01050120030015 · DOI
- 10.1177/1352458514538110 · DOI
- 10.1212/wnl.0000000000002774 · DOI
- 10.1002/ana.25462 · DOI · Paper page
- 10.1002/sim.5889 · DOI
- 10.1097/wno.0000000000000704 · DOI
- 10.1212/wnl.0000000000003144 · DOI · Paper page
- 10.1212/wnl.0000000000002975 · DOI · Paper page
- 10.1167/iovs.03-1213 · DOI
- 10.1016/j.jocn.2018.11.011 · DOI
- 10.1007/s00417-013-2337-0 · DOI
- 10.1212/wnl.0000000000006873 · DOI
- 10.1007/s13311-016-0479-6 · DOI
- 10.1093/brain/awv105 · DOI · Paper page
- 10.1093/brain/awm329 · DOI · Paper page
- 10.1177/1352458517721054 · DOI
Cited by
Sorted by citations
Saidha, S., Green, A. J., Leocani, L., Vidal-Jordana, A., Kenney, R. C., Bsteh, G., Outteryck, O., Thompson, A., Montalban, X., Coetzee, T., et al. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00275-3 · Cited by 66
Self-citationAdded value of optic nerve lesions for multiple sclerosis diagnostic criteria
Mahmoudi, N., Renne, J., Konen, F. F., Jendretzky, K. F., Möhn, N., Grote-Levi, L., Gingele, S., Hümmert, M. W., Schwenkenbecher, P., Soldatov, A., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13036-w · Cited by 4
Metadata
- Authors
- Bsteh, G., Hegen, H., Altmann, P., Auer, M., Berek, K., Di Pauli, F., Kornek, B., Krajnc, N., Leutmezer, F., Macher, S., Rommer, P. S., Zebenholzer, K., Zulehner, G., Zrzavy, T., Deisenhammer, F., Pemp, B., Berger, T., & for VMSD (Vienna Multiple Sclerosis Database) Group
- Affiliations
- Medical University of Vienna (AT)
- From the Department of Neurology (G.B., P.A., B.K., N.K., F.L., S.M., P.S.R., K.Z., G.Z., T.Z., T.B.), Medical University of Vienna; Comprehensive Center for Clinical Neurosciences and Mental Health (G.B., P.A., B.K., N.K., F.L., S.M., P.S.R., K.Z., G.Z., T.Z., T.B.), Medical University of Vienna; Department of Neurology (H.H., M.A., K.B., F.D.P., F.D.), Medical University of Innsbruck; and Department of Ophthalmology (B.P.), Medical University of Vienna, Austria.
- Corresponding author
- Bsteh, Gabriel
- ORCID
- Venue
- Neurology
- Published
- 2023-08-22
- Volume
- 101
- Issue
- 8
- Pages
- e784-e793
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC10449446
- OpenAlex
- W4382933499
- Cited by
- 59
- References
- 3
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 15 · 2023: 4
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Neurology (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Sanofi
- Biogen
- Teva Pharmaceutical Industries
- Alexion Pharmaceuticals
- Celgene
- European Committee for Treatment and Research in Multiple Sclerosis
- Amicus Therapeutics
- Santen
- MedDay Pharmaceuticals
- Allergan
- Sanofi Genzyme
- Cilag
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Retinal and Optic Conditions
- Keywords
- multiple sclerosis, dissemination in space, optic nerve, optical coherence tomography, 2017 McDonald criteria, diagnostic accuracy, first demyelinating event, optic neuritis, sensitivity and specificity
- MeSH terms
- Adult, Female, Humans, Male, Multiple Sclerosis, Optic Nerve, Optic Neuritis, Prospective Studies, Tomography, Optical Coherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review